170 related articles for article (PubMed ID: 32924793)
1. Potential Role of Targeting KDR and Proteasome Inhibitors in the Therapy of Esophageal Squamous Cell Carcinoma.
Zhang L; Niu X; Bi Y; Cui H; Li H; Cheng X
Technol Cancer Res Treat; 2020; 19():1533033820948060. PubMed ID: 32924793
[TBL] [Abstract][Full Text] [Related]
2. [Function and mechanism of zinc finger protein ZNF50 in inhibiting the growth of esophageal squamous cell carcinoma cells].
Wang J; Bi YH; Yang J; Liu F; Li YK; Cui HY; Wang F; Liu J; Yang B; Zhang L
Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):7-12. PubMed ID: 28104026
[No Abstract] [Full Text] [Related]
3. Novel ESCC-related gene ZNF750 as potential Prognostic biomarker and inhibits Epithelial-Mesenchymal Transition through directly depressing SNAI1 promoter in ESCC.
Kong P; Xu E; Bi Y; Xu X; Liu X; Song B; Zhang L; Cheng C; Yan T; Qian Y; Yang J; Ma Y; Cui H; Zhai Y; Zou B; Liu X; Cheng Y; Guo S; Cheng X; Cui Y
Theranostics; 2020; 10(4):1798-1813. PubMed ID: 32042337
[No Abstract] [Full Text] [Related]
4. Whole-exome sequencing reveals critical genes underlying metastasis in oesophageal squamous cell carcinoma.
Dai W; Ko JMY; Choi SSA; Yu Z; Ning L; Zheng H; Gopalan V; Chan KT; Lee NP; Chan KW; Law SY; Lam AK; Lung ML
J Pathol; 2017 Aug; 242(4):500-510. PubMed ID: 28608921
[TBL] [Abstract][Full Text] [Related]
5. Decreased ZNF750 promotes angiogenesis in a paracrine manner via activating DANCR/miR-4707-3p/FOXC2 axis in esophageal squamous cell carcinoma.
Bi Y; Guo S; Xu X; Kong P; Cui H; Yan T; Ma Y; Cheng Y; Chen Y; Liu X; Zhang L; Cheng C; Xu E; Qian Y; Yang J; Song B; Li H; Wang F; Hu X; Liu X; Niu X; Zhai Y; Liu J; Li Y; Cheng X; Cui Y
Cell Death Dis; 2020 Apr; 11(4):296. PubMed ID: 32341351
[TBL] [Abstract][Full Text] [Related]
6. Co-targeting PLK1 and mTOR induces synergistic inhibitory effects against esophageal squamous cell carcinoma.
Liu TT; Yang KX; Yu J; Cao YY; Ren JS; Hao JJ; Pan BQ; Ma S; Yang LY; Cai Y; Wang MR; Zhang Y
J Mol Med (Berl); 2018 Aug; 96(8):807-817. PubMed ID: 29959473
[TBL] [Abstract][Full Text] [Related]
7. Potential therapeutic effect of targeting glycogen synthase kinase 3β in esophageal squamous cell carcinoma.
Bolidong D; Domoto T; Uehara M; Sabit H; Okumura T; Endo Y; Nakada M; Ninomiya I; Miyashita T; Wong RW; Minamoto T
Sci Rep; 2020 Jul; 10(1):11807. PubMed ID: 32678196
[TBL] [Abstract][Full Text] [Related]
8. ZNF750 Expression Is a Potential Prognostic Biomarker in Esophageal Squamous Cell Carcinoma.
Otsuka R; Akutsu Y; Sakata H; Hanari N; Murakami K; Kano M; Toyozumi T; Takahashi M; Matsumoto Y; Sekino N; Yokoyama M; Okada K; Shiraishi T; Komatsu A; Iida K; Matsubara H
Oncology; 2018; 94(3):142-148. PubMed ID: 29216641
[TBL] [Abstract][Full Text] [Related]
9. EIF3H promotes aggressiveness of esophageal squamous cell carcinoma by modulating Snail stability.
Guo X; Zhu R; Luo A; Zhou H; Ding F; Yang H; Liu Z
J Exp Clin Cancer Res; 2020 Aug; 39(1):175. PubMed ID: 32867821
[TBL] [Abstract][Full Text] [Related]
10. Genomic analyses reveal mutational signatures and frequently altered genes in esophageal squamous cell carcinoma.
Zhang L; Zhou Y; Cheng C; Cui H; Cheng L; Kong P; Wang J; Li Y; Chen W; Song B; Wang F; Jia Z; Li L; Li Y; Yang B; Liu J; Shi R; Bi Y; Zhang Y; Wang J; Zhao Z; Hu X; Yang J; Li H; Gao Z; Chen G; Huang X; Yang X; Wan S; Chen C; Li B; Tan Y; Chen L; He M; Xie S; Li X; Zhuang X; Wang M; Xia Z; Luo L; Ma J; Dong B; Zhao J; Song Y; Ou Y; Li E; Xu L; Wang J; Xi Y; Li G; Xu E; Liang J; Yang X; Guo J; Chen X; Zhang Y; Li Q; Liu L; Li Y; Zhang X; Yang H; Lin D; Cheng X; Guo Y; Wang J; Zhan Q; Cui Y
Am J Hum Genet; 2015 Apr; 96(4):597-611. PubMed ID: 25839328
[TBL] [Abstract][Full Text] [Related]
11. Activation of histamine H
He GH; Ding JQ; Zhang X; Xu WM; Lin XQ; Huang MJ; Feng J; Wang P; Cai WK
J Mol Med (Berl); 2018 Sep; 96(9):951-964. PubMed ID: 30058054
[TBL] [Abstract][Full Text] [Related]
12. Differentiation-related zinc finger protein 750 suppresses cell growth in esophageal squamous cell carcinoma.
Ana Choi SS; Ko JM; Yu VZ; Ning L; Lung ML
Oncol Lett; 2021 Jul; 22(1):513. PubMed ID: 33986873
[TBL] [Abstract][Full Text] [Related]
13. Targeting SOX2 Protein with Peptide Aptamers for Therapeutic Gains against Esophageal Squamous Cell Carcinoma.
Liu K; Xie F; Zhao T; Zhang R; Gao A; Chen Y; Li H; Zhang S; Xiao Z; Li J; Hong X; Shang L; Huang W; Wang J; El-Rifai W; Zaika A; Chen X; Que J; Lan X
Mol Ther; 2020 Mar; 28(3):901-913. PubMed ID: 31991109
[TBL] [Abstract][Full Text] [Related]
14. MTA1 promotes tumorigenesis and development of esophageal squamous cell carcinoma via activating the MEK/ERK/p90RSK signaling pathway.
Nan P; Wang T; Li C; Li H; Wang J; Zhang J; Dou N; Zhan Q; Ma F; Wang H; Qian H
Carcinogenesis; 2020 Sep; 41(9):1263-1272. PubMed ID: 31783401
[TBL] [Abstract][Full Text] [Related]
15. A multi-kinase inhibitor APG-2449 enhances the antitumor effect of ibrutinib in esophageal squamous cell carcinoma via EGFR/FAK pathway inhibition.
Luo QY; Zhou SN; Pan WT; Sun J; Yang LQ; Zhang L; Qiu MZ; Yang DJ
Biochem Pharmacol; 2021 Jan; 183():114318. PubMed ID: 33159967
[TBL] [Abstract][Full Text] [Related]
16. TP63, SOX2, and KLF5 Establish a Core Regulatory Circuitry That Controls Epigenetic and Transcription Patterns in Esophageal Squamous Cell Carcinoma Cell Lines.
Jiang YY; Jiang Y; Li CQ; Zhang Y; Dakle P; Kaur H; Deng JW; Lin RY; Han L; Xie JJ; Yan Y; Doan N; Zheng Y; Mayakonda A; Hazawa M; Xu L; Li Y; Aswad L; Jeitany M; Kanojia D; Guan XY; Said JW; Yang W; Fullwood MJ; Lin DC; Koeffler HP
Gastroenterology; 2020 Oct; 159(4):1311-1327.e19. PubMed ID: 32619460
[TBL] [Abstract][Full Text] [Related]
17. The transcription factor LEF1 promotes tumorigenicity and activates the TGF-β signaling pathway in esophageal squamous cell carcinoma.
Zhao Y; Zhu J; Shi B; Wang X; Lu Q; Li C; Chen H
J Exp Clin Cancer Res; 2019 Jul; 38(1):304. PubMed ID: 31296250
[TBL] [Abstract][Full Text] [Related]
18. Promoter hypomethylation mediated upregulation of MicroRNA-10b-3p targets FOXO3 to promote the progression of esophageal squamous cell carcinoma (ESCC).
Lu YF; Yu JR; Yang Z; Zhu GX; Gao P; Wang H; Chen SY; Zhang J; Liu MY; Niu Y; Wei XM; Wang W; Ye FJ; Zhang LX; Zhao Y; Sun GG
J Exp Clin Cancer Res; 2018 Dec; 37(1):301. PubMed ID: 30514328
[TBL] [Abstract][Full Text] [Related]
19. HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway.
Wang H; Yang X; Guo Y; Shui L; Li S; Bai Y; Liu Y; Zeng M; Xia J
J Exp Clin Cancer Res; 2019 Jul; 38(1):324. PubMed ID: 31331361
[TBL] [Abstract][Full Text] [Related]
20. Intratumoral heterogeneity of esophageal squamous cell carcinoma and its clinical significance.
Wang X; Jia Y; Deng H; Liu Y; Liu Y
Pathol Res Pract; 2019 Feb; 215(2):308-314. PubMed ID: 30528923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]